Experimental drug targets 17 cancers sharing genetic defect - Genetic Literacy Project

Experimental drug targets 17 cancers sharing genetic defect Genetic Literacy Project Loxo Oncology Inc.'s drug, larotrectinib, was tested in patients who had one of 17 different types of cancer at an advanced stage, including rare ones like salivary-gland cancer and more common types like colon and lung cancers. The tumors had a rare ...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qW7uGB
via IFTTT